Leena Lauronen

Leena Lauronen

Auto-generated profile, based on publicly available information

Leena Lauronen

Epilepsia Helsinki, Department of Clinical Neurophysiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2019 in Scientific Data
Verified
Journal Article
Open access
PDF file
NSN. J. Stevenson
N. J. Stevenson
KTK. Tapani
K. Tapani
LLL. Lauronen
L. Lauronen
SVS. Vanhatalo
S. Vanhatalo
Neonatal seizures are a common emergency in the neonatal intensive care unit (NICU). There are many questions yet to be answered regarding the temporal/spatial characteristics of seizures from different pathologies, response to medication, effects on neurodevelopment and optimal detection. The dataset presented in this descriptor contains EEG recordings from human neonates, the visual interpretation of the EEG by the human experts, supporting clinical data and codes to assist access. Multi-channel EEG was recorded from 79 term neonates admitted to the NICU at the Helsinki University Hospital. The median recording duration was 74 min (IQR: 64 to 96 min). The presence of seizures in the EEGs was annotated independently by three experts. An average of 460 seizures were annotated per expert in the dataset; 39 neonates had seizures and 22 were seizure free, by consensus. The dataset can be used as a reference set of neonatal seizures, in studies of inter-observer agreement and for the development of automated methods of seizure detection and other EEG analyses.

2 July 1999 in Human Brain Mapping
Verified
Journal Article
Closed access
PDF file
AKAntti Korvenoja
Antti Korvenoja
JHJuha Huttunen
Juha Huttunen
ESEero Salli
Eero Salli
HPHanna Pohjonen
Hanna Pohjonen
SMSami Martinkauppi
Sami Martinkauppi
HAHannu J. Aronen
Hannu J. Aronen

17 March 2014 in Frontiers in Human Neuroscience
Verified
Journal Article
Open access
PDF file
PNPã¤Ivi Nevalainen
Pã¤Ivi Nevalainen
LLLeena Lauronen
Leena Lauronen
EPElina Pihko
Elina Pihko
The mysteries of early development of cortical processing in humans have started to unravel with the help of new noninvasive brain research tools like multichannel magnetoencephalography (MEG). In this review, we evaluate, within a wider neuroscientific and clinical context, the value of MEG in studying normal and disturbed functional development of the human somatosensory system. The combination of excellent temporal resolution and good localization accuracy provided by MEG has, in the case of somatosensory studies, enabled the differentiation of activation patterns from the newborn’s primary (SI) and secondary somatosensory (SII) areas. Furthermore, MEG has shown that the functioning of both SI and SII in newborns has particular immature features in comparison with adults. In extremely preterm infants, the neonatal MEG response from SII also seems to potentially predict developmental outcome: those lacking SII responses at term show worse motor performance at age two years than those with normal SII responses at term. In older children with unilateral early brain lesions, bilateral alterations in somatosensory cortical activation detected in MEG imply that the impact of a localized insult may have an unexpectedly wide effect on cortical somatosensory networks. The achievements over the last decade show that MEG provides a unique approach for studying the development of the somatosensory system and its disturbances in childhood. MEG well complements other neuroimaging methods in studies of cortical processes in the developing brain.

1 August 2009 in Clinical Neurophysiology
Verified
Journal Article
Closed access
EPElina Pihko
Elina Pihko
PNPäivi Nevalainen
Päivi Nevalainen
JSJulia Stephen
Julia Stephen
YOYoshio Okada
Yoshio Okada
LLLeena Lauronen
Leena Lauronen

1 December 2006 in Seminars in Fetal and Neonatal Medicine
Verified
Journal Article
Closed access
Sampsa VanhataloSampsa Vanhatalo
Sampsa Vanhatalo
LLLeena Lauronen
Leena Lauronen

1 January 1999 in Neurology
Verified
Journal Article
Closed access
LLL. Lauronen
L. Lauronen
PMP.B. Munroe
P.B. Munroe
IJI. JärVelä
I. JärVelä
TAT. Autti
T. Autti
HMH.M. Mitchison
H.M. Mitchison
PSP. Santavuori
P. Santavuori
Objective: To correlate the phenotypes with the genotypes of 10 Finnish juvenile neuronal ceroid lipofuscinosis (JNCL; late-onset Batten disease) patients who all are compound heterozygotes for the major 1.02-kb deletion in the CLN3 gene. Methods: The mutations on the non–1.02-kb deletion chromosomes were screened in 6 patients; in the other 4 patients the mutations were known (one affecting a splice site, two missense mutations, and one deletion of exons 10 through 13). Clinical features were examined, and MRI, MRS, somatosensory evoked magnetic field (SEF), and overnight polysomnography (PSG) studies were performed. Results: A novel deletion of exons 10 through 13 was found in 6 patients belonging to three families. In the patients carrying the deletions of exons 10 through 13 the clinical course of the disease was fairly similar. Variation was greatest in the time course to blindness. In these patients the mental and motor decline was slower than in classic JNCL, but more severe than in the two patients with missense mutations in exons 11 and 13. MRI showed brain atrophy in 4 patients. One patient had hyperintense periventricular white matter, otherwise brain signal intensities were normal. SEFs were enhanced in patients older than 14 years, whereas in PSG all but the youngest 6-year-old patient showed epileptiform activity in slow-wave sleep. Conclusions: JNCL can manifest as at least three different phenotypes: classic, delayed classic, and protracted JNCL with predominantly ocular symptoms. Finnish compound heterozygotes have the delayed classic or the protracted form of JNCL.